| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 83476 |
HS-(CH2)2-OH，巯基-烷烃-羟基 |
243 |
h |
2024-12-23 |
| 83477 |
TMCL Liposomes,特性与功能 |
182 |
axc |
2024-12-23 |
| 83478 |
MC-GGFG-NH-CH2-O-CH2-(s-cyclopropane)-COOH |
277 |
wyh |
2024-12-23 |
| 83479 |
3-巯基丙酸修饰的聚1-半胱氨酸[P(Cys-SS-CH2CH2COOH)] |
235 |
h |
2024-12-23 |
| 83480 |
TOCL Liposomes,心磷脂脂质体,定制服务 |
473 |
axc |
2024-12-23 |
| 83481 |
Galβ1-4(Fucα1-3)GlcNAcβ1-3Galβ-O-CH2-CH2-CH2-NH2，抗原四糖-βO-氨丙基 |
353 |
wyh |
2024-12-23 |
| 83482 |
Cardiolipin Liposomes,心磷脂脂质体 |
324 |
axc |
2024-12-23 |
| 83483 |
Biotin-PEG(4)-MeTz，1962919-31-8，生物素-聚乙二醇(4)-MeTz |
203 |
wyh |
2024-12-23 |
| 83484 |
DOTAP:DOPC Liposomes,特性与应用 |
326 |
axc |
2024-12-23 |
| 83485 |
HOOC-PMeOx(50)-N3，26375-28-0，HOCOCH2(C4H7NO)50N3 |
163 |
wyh |
2024-12-23 |
| 83486 |
Fmoc-Tyr(CH2-Chx)-OH，N-α-(9-芴基甲氧基羰基)-4-环己基甲氧基-L-苯丙氨酸 |
353 |
wyh |
2024-12-23 |
| 83487 |
cas:1337889-01-6，Ald-Ph-amido-PEG11-C2-NH2 |
148 |
zyl |
2024-12-23 |
| 83488 |
长链脂肪酸衍生物MAMA-(CH2)17COOH |
195 |
h |
2024-12-23 |
| 83489 |
cas:1807501-86-5，2,5-dioxopyrrolidin-1-yl 1-(bicyclo[6.1.0]non-4-yn-9-yl)-3-oxo-2,7,10,13,16-pentaoxa-4-azanonadecan-19-oate |
140 |
zyl |
2024-12-23 |
| 83490 |
1059189-65-9，m-PEG4-CH2-aldehyde |
161 |
wyh |
2024-12-23 |
| 83491 |
cas:886209-60-5，perfluorophenyl 2-(cyclooct-2-ynyloxy)acetate |
232 |
zyl |
2024-12-23 |
| 83492 |
DOOCCH2CH2COOD烷基链试剂 |
167 |
h |
2024-12-23 |
| 83493 |
cas:1092654-47-1，Azido-PEG3-CH2CO2-NHS |
150 |
wyh |
2024-12-23 |
| 83494 |
N-芴甲氧羰基-五聚乙二醇-乙酸，Fmoc-NH-PEG5-CH2COOH |
179 |
wyh |
2024-12-23 |
| 83495 |
cas:1232769-29-7，Mal-CO-PEG5-NHS ester |
183 |
zyl |
2024-12-23 |
| 83496 |
氨基-PEG4-丁酸，Amino-PEG4-(CH2)3CO2H |
204 |
wyh |
2024-12-23 |
| 83497 |
cas:1342211-31-7， MC-Val-Ala-OH |
156 |
zyl |
2024-12-23 |
| 83498 |
cas:150244‐18‐1，sulfo-LC-SPDP |
196 |
zyl |
2024-12-23 |
| 83499 |
Azido-PEG3-CH2CO2Me，叠氮-三聚乙二醇-CH2CO2甲基 |
286 |
wyh |
2024-12-23 |
| 83500 |
cas:663598-89-8，1-(4-((5-nitropyridin-2-yl)disulfanyl)butanoyloxy)-2,5-dioxopyrrolidine-3-sulfonic acid |
177 |
zyl |
2024-12-23 |
| 83501 |
99mTc-HYNIC-PEG4-E[PEG4-c（RGDfk）]2(即99mTc-3PRGD2) |
356 |
wyh |
2024-12-23 |
| 83502 |
cas:121115-30-8 SPDP-sulfo 2,5-dioxo-1-(3-(pyridin-2-yldisulfanyl)propanoyloxy)pyrrolidine-3-sulfonic acid |
191 |
zyl |
2024-12-23 |
| 83503 |
MP-PEG8-Val-Ala-PAB-(imp)PBD的组成部分 |
206 |
wyh |
2024-12-23 |
| 83504 |
perfluorophenyl 3-(2-(2-(2-(1,3-dioxoisoindolin-2-yloxy)ethoxy)ethoxy)ethoxy)propanoate |
202 |
zyl |
2024-12-23 |
| 83505 |
MC-Val-Cit-PABC-BF211，抗体药物偶联物(ADCs) |
245 |
wyh |
2024-12-23 |
| 83506 |
2,3,4,5,6-pentafluorophenyl 3-[2-(2-{2-[(4-formylphenyl)formamido]ethoxy}ethoxy)ethoxy]propanoate |
143 |
zyl |
2024-12-23 |
| 83507 |
DOPG:DOPC Liposomes,磷脂酰甘油与磷脂酰胆碱脂质体 |
506 |
axc |
2024-12-23 |
| 83508 |
cas:1353012-00-6，perfluorophenyl 1-azido-3,6,9,12-tetraoxapentadecan-15-oate |
179 |
zyl |
2024-12-23 |
| 83509 |
1V209-PEG23-TA ， 4，7，10-三氧杂-1，13-十三烷二胺和α-甘露糖 |
250 |
wyh |
2024-12-23 |
| 83510 |
cas:943858-70-6，Azidobutyric acid NHS ester |
238 |
zyl |
2024-12-23 |
| 83511 |
DOPG Liposomes,磷脂酰甘油脂质体 |
193 |
axc |
2024-12-23 |
| 83512 |
(64)Cu-NOTA-PEG4-LLP2A的结构组成 |
168 |
wyh |
2024-12-23 |
| 83513 |
99mTc(CO)3-DPA-DBCO-PEG4-CTT-54的显像效果 |
229 |
wyh |
2024-12-23 |
| 83514 |
DOPS:DOPC Liposomes,磷脂酰丝氨酸与磷脂酰胆碱脂质体 |
544 |
axc |
2024-12-23 |
| 83515 |
2,5-dioxopyrrolidin-1-yl 11-oxo-4,7,13-trioxa-10-azahexadec-15-yn-1-oate |
174 |
zyl |
2024-12-23 |
| 83516 |
DOPC Liposomes,二油酰磷脂酰胆碱脂质体 |
249 |
axc |
2024-12-23 |
| 83517 |
DTPA(Gd)-PEG8-(FY)3的结构特点 |
175 |
wyh |
2024-12-23 |
| 83518 |
Fucα1-2Gal-O-(CH2)3-NH-CS-NH-Fluorescein |
171 |
h |
2024-12-23 |
| 83519 |
DSPC Liposomes,二硬脂酰磷脂酰胆碱脂质体 |
319 |
axc |
2024-12-23 |
| 83520 |
GlcNAcβ1-3Galβ1-4Glc-O-(CH2)3-NH-Lipoic |
197 |
h |
2024-12-23 |
齐岳微信公众号
官方微信
库存查询